Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2025 10:43 ET | Source: Research and Markets

2025 Global Research: Hematology Analyzers and Reagents Market Projected to Reach $3.28 Billion by 2030, Driven by Technological Advances and Rising Demand for Diagnostic Precision

Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2020-2030F" report has been added to ...
April 12, 2023 08:40 ET | Source: CMI

Monoclonal Antibody Therapeutics Market to Surpass US$ 534.26 Billion by 2030, Says Coherent Market Insights (CMI)

Burlingame, April 12, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global Monoclonal Antibody Therapeutics Market is estimated to be valued at US$ 205.39 Billion in 2023 and is...
October 28, 2020 06:53 ET | Source: Research and Markets

Global Hematology and Coagulation Testing Markets Report 2020 with Discussion of COVID-19

Dublin, Oct. 28, 2020 (GLOBE NEWSWIRE) -- The "Hematology and Coagulation Markets (Lab-based and Decentralized Markets)" report has been added to ResearchAndMarkets.com's offering. Hematology and...
March 26, 2009 12:54 ET | Source: HemaQuest Pharmaceuticals

HemaQuest Pharmaceuticals Receives European Orphan Medicinal Product Designations for Therapeutic to Treat Hemoglobin Disorders

BOSTON, MA--(Marketwire - March 26, 2009) - HemaQuest Pharmaceuticals today announced that it has received two orphan medicinal product designations from the European Commission for its product...
December 09, 2008 12:01 ET | Source: HemaQuest Pharmaceuticals

HemaQuest Pharmaceuticals Announces Clinical Progress on New Sickle Cell Anemia Drug

SAN FRANCISCO, CA--(Marketwire - December 9, 2008) - HemaQuest Pharmaceuticals announced today the successful completion of Phase 1 clinical trials of HQK-1001, an orally-administered therapeutic...